Over time, this can lead to loss of lean mass, reduced metabolic rate, and suboptimal body composition outcomes
Key timing considerations: The glucagon component may cause increased energy and warmth, which some researchers prefer in the morning rather than before bed Dose scheduling follows similar principles to other weekly GLP-1 formulations Injection site rotation follows the same principles outlined in the retatrutide injection guide Triple agonist mechanism means monitoring for unique side effects that may have their own timing patterns Being investigational, less real-world timing data exists compared to approved medications What to do when you miss your injection window It happens to everyone
A 2022 review in Diabetes Care noted that GI motility changes from GLP-1 receptor agonists can cause both accelerated small bowel transit in some individuals and paradoxical constipation in others, depending on regional receptor distribution [5]
Food noise is the intense, persistent preoccupation with food caused by imbalances in diet regulation,
The subsequent phase 3 trial of tirzepatide demonstrated more effective reductions in the glycated hemoglobin levels and body weight, along with greater overall improvements in the lipid profile compared to semaglutide in patients with T2DM, elevating incretin therapeutic agents to a new level (112)
"Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study"